换一批
换一批Biologic treatments for psoriasis in China: current status and potential tuberculosis and hepatitis B virus risks
摘要Introduction Psoriasis is a chronic,recurrent skin disease featured by scaly papules or plaques.Although the vast majority of patients have mild psoriasis,approxi-mately 20％-30％ of patients have moderate or severe psoriasis,which is defined as body surface area (BSA) ＞ 10,psoriasis area and severity index (PASI) ＞ 10,and dermatology life quality index (DLQI) ＞ 10.These patients have severe symptoms and worse quality of life,warranting consideration of systemic therapy[1].Biologic treatments directly target specific steps in the pathogenesis of psoriasis,providing a revolution for treatment.
更多相关知识
栏目名称
DOI
10.3760/cma.j.issn.2096-5540.2018.02.006
发布时间
2018-08-13
- 浏览48
- 被引2
- 下载16
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
